Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Conditions:   Critical Illness;   New Onset Atrial Fibrillation Interventions:   Drug: Magnesium sulfate;   Drug: Placebo Sponsors:   Queen's University;   Southeastern Ontario Academic Medical Organization (SEAMO) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials